First meningitis B vaccine could be available in UK next yearBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7867 (Published 20 November 2012) Cite this as: BMJ 2012;345:e7867
- Gareth Iacobucci
The first vaccine for meningitis B is set to become available in the United Kingdom next year after being recommended by the European Medicines Agency.
The agency’s Committee for Medicinal Products for Human Use (CHMP) has granted marketing authorisation for Bexsero, a new vaccine from Novartis intended to immunise people aged 2 months or older against invasive meningococcal disease caused by Neisseria meningitidis group B.
If accepted, the vaccine could become available in the UK next year, subject to approval from the UK Joint Committee for Vaccination and Immunisation, which is currently assessing the vaccine for inclusion …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial